Therefore, we undertook bioinformatics analysis and in vivo experiments in the PD model to illuminate a more efficacious personalized treatment strategy for PD by regulating dysbiosis of gut microbiota-mediated NMNAT2. Here, NMNAT2 is linked to Parkinson disease.